glp-1 psychiatry Insights into a possible role of glucagon-like peptide-1 receptor agonists in the treatment of depression | Pharmacological Reports Repurposing GLP-1 Receptor Agonists for

Case Report: Semaglutide-associated depression: a report of two cases

Tirzepatide, effects, safety and antidepressants belong close to the Tirzepatide and Antidepressants safety discussion so readers can separate common discomfort from symptoms that deserve medical follow-up

The RECONNECT trials delivered statistically significant improvements in both desire scores and distress in over 1,200 women, the cardiovascular effects are characterized and manageable, and nausea the dominant side effect diminishes with repeated use

doi: 10.1016/j.bbagen.2014.11.021 114

From the information we have, patients really should be able to fill their prescriptions. In other words for now, it seems you really can keep calm and continue to take your Zoloft.